Profil
Business Services · Germany · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Hellersbergstr. 9, Neuss, Nordrhein-West...Phone Number
+49 21314018345Website
www.profil.comRevenue
$80.3 MillionIndustry
About Profil
Profil Org Chart
Is Profil your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Profil
Click to see if Profil had a recent Job posting/layoffs
Earning: See what the market has to say on Profil recently announced quarterly report
Product Launch: Get notified when Profil launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Profil is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Profil has new funding data
Check if Profil has recently received funding, and reach out quickly before it becomes old news!
Profil, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Profil as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Profil is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Profil is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Profil.
Profil Tech Stack
A closer look at the technologies used by Profil
Most Recent Scoops
Profil News & Media
Civica Selects Profil as Clinical Trial Partner for Affordable Insulin Initiative
LEHI, Utah--(BUSINESS WIRE)--Civica, Inc. (Civica, Civica Rx) today announced the selection of Profil, Neuss, Germany, as its clinical trial partner to support the development of its affordable insulins. As previously announced, Civica plans to produce three insulin biosimilars – glargine, lispro and aspart – each of which will be available both in vials and prefilled pens, and sell the insulins at significantly lower prices than insulins currently on the market. Human clinical trials are anChristoph Kapitza - Chief Executive Officer at Profil | The Org
Christoph has over 20 years of diabetes research experience in the development of drugs, devices and drug-device combination products. He has consulted in the clinical development plans (phase I through to post-marketing studies) of several new therapeutic entities. Dr. Kapitza has particular interest and expertise in the field of incretin hormones.PROFIL® lanceert nieuwe website
DANBORO, Pa.--(BUSINESS WIRE)--PROFIL®, een PennEngineering®-bedrijf en toonaangevende wereldwijde fabrikant van mechanisch verbonden bevestigingsmiddelen voor de automobielmarkt, heeft de lancering aangekondigd van een nieuwe website, www.profil-global.com. De nieuwe website, beschikbaar in het Engels en Duits, biedt bezoekers een verbeterde gebruikerservaring die het gemakkelijk maakt om meer te weten te komen over PROFIL®-producten, -installatiemethoden en -applicatiegebruik. Naast het zeerPROFIL® lancia un nuovo sito web
DANBORO, Pennsylvania--(BUSINESS WIRE)--PROFIL®, una società PennEngineering® e leader mondiale nella produzione di dispositivi di fissaggio per giunzioni non permanenti (MAF, mechanically attached fasteners) per il settore automotive, ha annunciato il lancio di un nuovo sito web, www.profil-global.com. Disponibile in inglese e tedesco, il nuovo sito web offre ai visitatori un’esperienza d’uso migliorata che consente di attingere facilmente informazioni sui prodotti PROFIL®, i relativi metodi d
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Profil
Profil is the world's leading clinical research organization (CRO) specializing in diabetes and obesity research. They offer a comprehensive range of services including pharmacodynamics, pharmacokinetics, and safety studies, focusing on the development of diabetes treatments and medical technologies. With expertise in glucose clamp studies and a co... Read More